Skip to content

Use of Water Ingestion in Small Intestine Ultrasound

Use of Water Ingestion to Improve Visualisation in Small Intestine Ultrasound (WIVIUS): Single Centre Blinded Crossover Trial

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07079007
Enrollment
55
Registered
2025-07-22
Start date
2025-07-31
Completion date
2026-02-28
Last updated
2025-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Crohn Disease (CD), Intestine Ultrasonography

Keywords

small bowel contrast ultrasound

Brief summary

Small Intestine Contrast Ultrasonography (SICUS) is an ultrasound-based method that explores bowel loops, and is able to identify wall thickness, intestinal motility, bowel wall vascularity and complications such as stenosis or dilatation. Previous studies have utilised oral ingestion of an oral contrast solution (usually PEG dissolved in a volume of water ranging from 250 to 1000mL), in order to increase the sensitivity of ultrasound, especially in stricture detection. Parameters that have been improved include lumen distension to better delineate bowel wall layers, and improved peristalsis. Diffusion of this technique has been limited, in part due to PEG-based agents being costly, time consuming and are not tolerated well in some individuals. Utilisation of water as oral contrast may improve patient tolerability and therefore increase uptake of water ingested intestinal contrast ultrasound (WICUS) as a technique in routine clinical practice. The investigators aim to study the tolerability and the improvement of image quality utilising water as an oral contrast for intestinal ultrasonography.

Interventions

OTHERWater

Patients that meet the inclusion and exclusion criteria would be asked to ingest 1000ml water as part of standard of care.

Sponsors

Austin Health
Lead SponsorOTHER_GOV

Study design

Observational model
CASE_CROSSOVER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

All consecutive patients at baseline scan with: * Confirmed or suspected Crohn's disease with small bowel involvement * Increased bowel wall thickness (\>3mm) of the terminal ileum * Suboptimal luminal distension of the terminal ileum 3cm proximal to ICV and 1cm proximal to diseased segment (defined as \<8mm) * All patients with an ileo-colic anastomosis

Exclusion criteria

* Presence of an ostomy * Adequate distension at baseline scan * Patients with ileo-rectal anastomosis or IPAA

Design outcomes

Primary

MeasureTime frameDescription
Improvement of luminal distension of the terminal ileumAt the post-water ingestion scan 20-30 minutes after ingestionImprovement of luminal distension of the terminal ileum, defined as increase of 20% over baseline luminal diameter at the terminal ileum if no disease, taking the average as measured at 1cm intervals over 3cm of the TI in longitudinal view. If diseased segment is present, then measurements would be done at 1cm intervals over 3cm proximal to the diseased segments.

Secondary

MeasureTime frameDescription
Is image quality and visualisation of the terminal/distal ileum improved post water ingestion during intestinal ultrasound compared to baseline as assessed by blinded sonographersAt the time of post-water ingestion scan 20-30 minutes after ingestionRecordings of the IUS would be recorded and de-identified Pre-contrast Cineloop x 1 of 10second duration encompassing the caecum, ileocaecal valce, terminal ileum extending to distal ileum Post-contrast Cineloop x 1 of 10second duration encompassing the caecum, ileocaecal valce, terminal ileum extending to distal ileum De-identified cineloops will then be randomised in a paired fashion (2 x cineloops baseline and 2 x cineloops post-contrast), and 3 external blinded sonographers will then be invited to review the cineloops - no limitation to number of times - and complete a questionnaire. Based on before and after CINE look in random order Global (overall image) assessment. Options: Better / Unchaged / Worse of CINEloop 1 compared to CINEloop 2

Other

MeasureTime frameDescription
Identification of suspected strictureAt the post-water ingestion scan 20-30 minutes after ingestionIdentification of suspected stricture with documentation of changes post WICUS (measured luminal distension in millimeters)
Measurement of bowel wall thicknessAt the post-water ingestion scan 20-30 minutes after ingestionBowel wall thickness of the terminal ileum and any diseased segment (in millimeters)
Measurement of hyperaemia of the bowel wall of any diseased terminal ileal segmentAt the post-water ingestion scan 20-30 minutes after ingestionAssessment of the bowel wall with colour doppler, and grading hyperaemia with the modified Limberg score (0 = no vascularity, 1 = localised vascularity, 2 = extensive vascularity, 3 = hyperemia extending into mesentery)
Pre-stenotic dilatationAt the post-water ingestion scan 20-30 minutes after ingestionMeasurement of prestenotic luminal distension (in millimeters) proximal to any diseased terminal ileum segment
Global assessment as assessed by blinded assessorsAt the post-water ingestion scan 20-30 minutes after ingestionLikert scale (5 point) global assessment 1-5 (1=Poor/inadequate views, 5=excellent view)
Distension assessmentAt the post-water ingestion scan 20-30 minutes after ingestionBinary assessment of distension - either poor or adequate
Diet effeect on the studyAt the post-water ingestion scan 20-30 minutes after ingestionTo determine if fasted patients (\>2 hours no fluid and \>3 hours no solid food \[meal/snack/nothing\]) were more likely to be included in the study due to lesser luminal distention
Grade of peristalsisAt the time of post-water ingestion scan 20-30 mins after ingestionAt the time of scan, determine grade of peristalsis (hyperkinetic, normal, decreased, absent)

Countries

Australia

Contacts

Primary ContactSheng Wei Lo, MBBS
shengwei.lo@austin.org.au+61 3 94965000

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026